Large-scale testing (Phase 3)Study completedNCT00121108
What this trial is testing
MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States
Who this might be right for
Healthy
MedImmune LLC 2,127